Neurocrine Biosciences (NBIX) operating margin

Operating margin · fiscal 2025
22.3%

Neurocrine Biosciences (NBIX) had an operating margin of 22.3% in fiscal 2025 (the year ended December 31, 2025). That is 2.5 percentage points lower than the 24.8% of fiscal 2024. Figures as of 18 Nov 2026, 00:24 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
22.3%
Change on fiscal 2024
−2.5 pts
Highest on record
43.8%fiscal 2011
Lowest on record
-1817.5%fiscal 2009
Fiscal years on record
162009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Neurocrine Biosciences operating margin, in more detail

Across the 16 fiscal years on record (2009–2025), the highest was 43.8% in fiscal 2011 and the lowest -1817.5% in fiscal 2009. The fiscal 2025 figure is higher than in 87% of the 15 earlier fiscal years on record, whose median is 8.2%.

Gross margin was 98.2% in fiscal 2025. Net margin was 16.7% in fiscal 2025.

History · 16 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Neurocrine Biosciences operating margin, year by year

Neurocrine Biosciences (NBIX) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
202522.3% 2.5 pts down98.2%16.7%
202424.8% 3.8 pts up98.6%14.5%
202320.9% 4.2 pts up97.9%13.2%
202216.7% 7.7 pts up98.4%10.4%
20219.0% 6.5 pts down—7.9%
202015.6% 6.4 pts up—38.9%
20199.2% 1.0 pts up—4.7%
20188.2% 89.4 pts up—4.7%
2017-81.3% 901.2 pts up—-88.2%
2016-982.5% 506.0 pts down—-940.6%
2015-476.5%——-449.8%
2013-1701.9% 1704.6 pts down—-1579.0%
20122.7% 41.1 pts down—9.5%
201143.8% 84.8 pts up—48.5%
2010-41.0% 1776.5 pts up—-23.8%
2009-1817.5%——-1728.3%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Neurocrine Biosciences and comparable companies
CompanyOperating marginFiscal year
Revvity RVTY12.5%2025
Exelixis EXEL38.5%2025
Charles River Laboratories International CRL10.0%2025
Neurocrine Biosciences NBIX22.3%2025
Ascendis Pharma ASND-18.9%2025
ICON ICLR12.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NBIX

Neurocrine Biosciences, figure by figure

Neurocrine Biosciences (NBIX) overview: price, valuation and scorecardAll health care companies by market value

Neurocrine Biosciences operating margin: questions and answers

What is Neurocrine Biosciences's operating margin?

Neurocrine Biosciences (NBIX) had an operating margin of 22.3% in fiscal 2025 (the year ended December 31, 2025). That is 2.5 percentage points lower than the 24.8% of fiscal 2024.

Is Neurocrine Biosciences's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 87% of the 15 earlier fiscal years on record, whose median is 8.2%.

What are the highest and lowest operating margin figures on record for Neurocrine Biosciences?

Across the 16 fiscal years on record (2009–2025), the highest was 43.8% in fiscal 2011 and the lowest -1817.5% in fiscal 2009.

What are Neurocrine Biosciences's gross and net margins?

Gross margin was 98.2% in fiscal 2025. Net margin was 16.7% in fiscal 2025.

How is Neurocrine Biosciences's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Neurocrine Biosciences (NBIX) operating margin”, data as of 18 November 2026. https://funkfolio.com/stock/NBIX/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.